Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea [Phase 2]

View source ↗

Summary

Phase 2 trial update for microbiota restoration therapy in recurrent Clostridium difficile infection; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Drugs mentioned

• Rebiotix Inc. (therapy likely RBX2660 / microbiota restoration therapy)

Snippet

Sponsor: Rebiotix Inc. | Conditions: Recurrent Clostridium Difficile Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-07-01